Share Name Share Symbol Market Type Share ISIN Share Description
Sareum Holdings Plc LSE:SAR London Ordinary Share GB00B02RFS12 ORD 0.025P
  Price Change % Change Share Price Shares Traded Last Trade
  0.035 5.11% 0.72 17,895,761 10:27:27
Bid Price Offer Price High Price Low Price Open Price
0.70 0.74 0.785 0.695 0.695
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -1.68 -0.05 22
Last Trade Time Trade Type Trade Size Trade Price Currency
16:19:25 O 300,000 0.738 GBX

Sareum (SAR) Latest News

More Sareum News
Sareum Takeover Rumours

Sareum (SAR) Discussions and Chat

Sareum Forums and Chat

Date Time Title Posts
26/5/202014:43Sareum 2015 4,073
12/5/202010:45The Sunday Afternoon Research Thread53
21/4/202002:392011 YEAR OF SAR8
17/4/202008:582012 Sareum Unleashed4,548
20/11/201917:27COOLABI next exciting stock take a look? epic COO5

Add a New Thread

Sareum (SAR) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
2020-05-26 15:19:270.74300,0002,214.00O
2020-05-26 15:05:080.745,35239.50O
2020-05-26 14:36:140.743832.83O
2020-05-26 13:18:260.74100,000738.00O
2020-05-26 12:42:310.7432,182237.50O
View all Sareum trades in real-time

Sareum (SAR) Top Chat Posts

Sareum Daily Update: Sareum Holdings Plc is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker SAR. The last closing price for Sareum was 0.69p.
Sareum Holdings Plc has a 4 week average price of 0.59p and a 12 week average price of 0.24p.
The 1 year high share price is 1.08p while the 1 year low share price is currently 0.24p.
There are currently 3,071,364,219 shares in issue and the average daily traded volume is 10,721,151 shares. The market capitalisation of Sareum Holdings Plc is £22,113,822.38.
norma_stitts: June 13th 2019; Dr Tim Mitchell, CEO of Sareum Holdings, commented: "We believe there is a clear opportunity to generate significant value for our shareholders over the next 12 months, given recent progress with both our clinical and preclinical programmes.” Could be hearing something at any point!?! Ok, we were hovering around the 0.55p mark at that point so some would argue we already have ‘significant value’ based on the current share price however it’s a very subjective word. For me, ‘significant’ would be something transformational.
bobby.ifa: It always worries me when a stock like SAR surges & people start the wild/hopeful share price forecasts. Leave the stock to do it's own thing.
cerrito: I note that people have wondered why there has been no comment from the company on the almost doubling of the price from sub 35p lunchtime Thursday to the mid 60's 48 trading hours later yesterday afternoon and note the report of increased volumes. A fair question and I thought that perhaps they have never dome this even with the volatility this share price has seen over the last 10 years plus.. I see they did make comments on share price movements in July 2016, March 20 16, August 2012 and Feb 2011. I have to say that I have become so accustomed to the price being in the 20's,30's and 40's that it surprised me to see that even after the last two days, it is still under the price of this time last year. I sold just over 15% of my holding in the 67 range yesterday afternoon and somewhat surprised to see it has gone above that at close.
hotorcold: Sareum will not let this chance pass. They have something that even if it doesn't succeed in the fight against Covid 19 will see the share price multiply whilst testing is undertaken, and giving them the chance to raise capital at a much higher share price and securing the companies future
rfcmoore66: With respect I think his, and my, problem is that earlier this year the share price was at least twice what it is now! How is that progress?
cerrito: No surprise that the Sierra share price opened basically unchanged at 50c and note its marcap is us37m which illustrates its lack of financial flexibility.
cerrito: The current FX rate is doing nothing for the share price.
cerrito: At least SAR share price up; at time of writing, SRA down at US1.04
spacedust: Marten & Co values Sareum’s 27.5% economic interest in SRA737 at £20.3m and places an indicative value on its TYK2 assets of £8-16m, representing a modest upgrade from its previous position. This suggests an overall value for Sareum of £25-35m (0.87-1.14p/share), which offers up to 63% upside to the current share price
cerrito: Sierra have just announced quote Sierra Oncology Announces Late-Breaking Oral and Poster Presentations at AACR 2019 for SRA737 and SRA141 Preclinical Data unquote I look forward to Mrs A's insight if this will move the dial for the SAR price. I see that Sierra's share price has had a good last month going up from 1.34 to 1.82 but still way below the 52 week high of 3.70
Sareum share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20200527 04:00:18